Conte PF - Search Results

1

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

Baldini E, Tibaldi C, Chella A, Angeletti CA, Silvano G, Andrei A, Algeri R, Conte PF. Baldini E, et al. Among authors: conte pf. Ann Oncol. 1996 Sep;7(7):747-9. doi: 10.1093/oxfordjournals.annonc.a010726. Ann Oncol. 1996. PMID: 8905035 Free article. Clinical Trial.

2

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.

Conte PF, Bruzzone M, Carnino F, Chiara S, Donadio M, Facchini V, Fioretti P, Foglia G, Gadducci A, Gallo L, et al. Conte PF, et al. J Clin Oncol. 1991 Apr;9(4):658-63. doi: 10.1200/JCO.1991.9.4.658. J Clin Oncol. 1991. PMID: 2066762 Clinical Trial.

3

Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.

Pronzato P, Brema F, Amoroso D, Bertelli G, Conte PF, Martini MC, Pastorino G, Rosso R. Pronzato P, et al. Among authors: conte pf. Breast Cancer Res Treat. 1990 Nov;17(1):51-4. doi: 10.1007/BF01812684. Breast Cancer Res Treat. 1990. PMID: 2095927 Clinical Trial.

4

Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimens.

Repetto L, Chiara S, Pace M, Guido T, Bruzzone M, Oliva C, Murolo C, Conte PF, Rosso R. Repetto L, et al. Among authors: conte pf. Tumori. 1990 Jun 30;76(3):274-7. doi: 10.1177/030089169007600313. Tumori. 1990. PMID: 2195729

5

Crossover study with cisplatin or carboplatin in advanced ovarian cancer.

Repetto L, Chiara S, Mammoliti S, Guido T, Bruzzone M, Secondo V, Donadio G, Odicino F, Ragni N, Conte PF, et al. Repetto L, et al. Among authors: conte pf. Gynecol Oncol. 1990 Nov;39(2):146-9. doi: 10.1016/0090-8258(90)90422-h. Gynecol Oncol. 1990. PMID: 2227588 Clinical Trial.

6

The role of surgery in the combined treatment of locally advanced breast cancer.

Canavese G, Catturich A, Battistini G, Caroti C, Pronzato P, Gardin G, Amoroso D, Bertelli G, Conte PF, Tomao S, et al. Canavese G, et al. Among authors: conte pf. Oncology. 1989;46(6):353-6. doi: 10.1159/000226749. Oncology. 1989. PMID: 2587002 Clinical Trial.

7

Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.

Pronzato P, Campora E, Amoroso D, Bertelli G, Botto F, Conte PF, Sertoli MR, Rosso R. Pronzato P, et al. Among authors: conte pf. Am J Clin Oncol. 1989 Dec;12(6):481-5. doi: 10.1097/00000421-198912000-00004. Am J Clin Oncol. 1989. PMID: 2589228

8

Phase II study of lonidamine in metastatic breast cancer.

Pronzato P, Amoroso D, Bertelli G, Conte PF, Cusimano MP, Ciottoli GB, Gulisano M, Lionetto R, Rosso R. Pronzato P, et al. Among authors: conte pf. Br J Cancer. 1989 Feb;59(2):251-3. doi: 10.1038/bjc.1989.51. Br J Cancer. 1989. PMID: 2930690 Free PMC article.

9

Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study.

Amoroso D, Pronzato P, Bertelli G, Gallotti P, Pastorino G, Cusimano MP, Merlano M, Conte PF, Rosso R. Amoroso D, et al. Among authors: conte pf. Breast Cancer Res Treat. 1988 Jul;11(3):269-71. doi: 10.1007/BF01807286. Breast Cancer Res Treat. 1988. PMID: 3167233

10

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.

Conte PF, Bruzzone M, Chiara S, Sertoli MR, Daga MG, Rubagotti A, Conio A, Ruvolo M, Rosso R, Santi L, et al. Conte PF, et al. J Clin Oncol. 1986 Jun;4(6):965-71. doi: 10.1200/JCO.1986.4.6.965. J Clin Oncol. 1986. PMID: 3519886 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters